(Q36135888)

12 August 2017

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland (English)

1 reference

12 August 2017

0 references

1 reference

1

Auvinen A

1 reference

12 August 2017

Tammela T

2

1 reference

12 August 2017

Stenman UH

3

1 reference

12 August 2017

Uusi-Erkkilä I

4

1 reference

12 August 2017

Leinonen J

5

1 reference

12 August 2017

Schröder FH

6

1 reference

12 August 2017

Hakama M

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

4

1 reference

12 August 2017

568-572

1 reference

Data quality and quality control of a population-based cancer registry. Experience in Finland

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Breast cancer screening as public health policy in Finland

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Pilot study of screening for prostate cancer in general practice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Serum prostate specific antigen as pre-screening test for prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Screening for prostatic carcinoma with prostate specific antigen

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Prostate-specific antigen levels and subsequent prostate cancer: potential for screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Effect of a mass screening program on the risk of cervical cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074672

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

23 September 2018

1 reference

12 December 2020

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

12 December 2020

Complex formation between PSA isoenzymes and protease inhibitors

1 reference

12 December 2020

Prostate-specific antigen in serum from blood donors with subsequent prostate cancer diagnosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.402

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8761371

1 reference